Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brian Fennerty

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gastroenterology|August 2, 2003
Gastric intestinal metaplasia on routine endoscopic biopsyM Brian Fennerty
Gastrointestinal Endoscopy|July 23, 2003
Endoscopic ablation of Barrett's related neoplasia: what is the evidence supporting its use?M Brian Fennerty
Cleveland Clinic Journal of Medicine|January 7, 2004
The continuum of GERD complicationsM Brian Fennerty
Current Gastroenterology Reports|November 21, 2002
COX-2 inhibition: does it save the stomach and sacrifice the heart, or can we have out cake and eat it too?M Brian Fennerty
Gastrointestinal Endoscopy Clinics of North America|June 12, 2003
Endoscopic therapy for gastroesophageal reflux disease: what have we learned and what needs to be done?M Brian Fennerty
Gastrointestinal Endoscopy|March 4, 2003
Endoscopic suturing for treatment of GERDM Brian Fennerty
Gastrointestinal Endoscopy Clinics of North America|August 15, 2003
Endoscopic diagnosis and surveillance of Barrett's esophagusM Brian Fennerty
Critical Care Medicine|June 20, 2002
Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppressionM Brian Fennerty
Reviews in Gastroenterological Disorders|May 31, 2003
Traditional therapies for irritable bowel syndrome: an evidence-based appraisalM Brian Fennerty
Reviews in Gastroenterological Disorders|December 13, 2002
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?M Brian Fennerty
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gastroenterology|August 2, 2003
Gastric intestinal metaplasia on routine endoscopic biopsyM Brian Fennerty
Gastrointestinal Endoscopy|July 23, 2003
Endoscopic ablation of Barrett's related neoplasia: what is the evidence supporting its use?M Brian Fennerty
Cleveland Clinic Journal of Medicine|January 7, 2004
The continuum of GERD complicationsM Brian Fennerty
Current Gastroenterology Reports|November 21, 2002
COX-2 inhibition: does it save the stomach and sacrifice the heart, or can we have out cake and eat it too?M Brian Fennerty
Gastrointestinal Endoscopy Clinics of North America|June 12, 2003
Endoscopic therapy for gastroesophageal reflux disease: what have we learned and what needs to be done?M Brian Fennerty
Gastrointestinal Endoscopy|March 4, 2003
Endoscopic suturing for treatment of GERDM Brian Fennerty
Gastrointestinal Endoscopy Clinics of North America|August 15, 2003
Endoscopic diagnosis and surveillance of Barrett's esophagusM Brian Fennerty
Critical Care Medicine|June 20, 2002
Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppressionM Brian Fennerty
Reviews in Gastroenterological Disorders|May 31, 2003
Traditional therapies for irritable bowel syndrome: an evidence-based appraisalM Brian Fennerty
Reviews in Gastroenterological Disorders|December 13, 2002
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?M Brian Fennerty
Pageof 6